Breaking News

SPI Pharma Expands Mannogem Mannitol Product Portfolio

Supports the development, manufacture and administration of oral dosage forms

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

SPI Pharma has expanded its line of Mannogem Mannitol products for use in multiple patient-friendly oral dosage forms to now include: Man-nogem XL Opal, Mannogem XL Ruby, Mannogem Emerald, and Mannogem Onyx.   SPI Pharma has applied its proprietary manufacturing technology to address mannitol’s inherently poor compressibility, producing new multifunctional, compendial grades of mannitol with superior binding and quick disintegration properties, greater compressibility, and tight particle size ra...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters